Vietnam Noninvasive Prenatal Testing Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

Vietnam Noninvasive Prenatal Testing Market Overview

The Vietnam Noninvasive Prenatal Testing market is valued at USD 140 million, based on a five-year historical analysis of the broader prenatal and diagnostic testing landscape and the growing contribution of NIPT within this segment. This growth is primarily driven by increasing awareness of prenatal health, advancements in genetic testing technologies, and a rising number of expectant mothers seeking early screening options. The demand for noninvasive prenatal testing (NIPT) has surged as it offers a safer alternative to invasive procedures such as amniocentesis and chorionic villus sampling, which carry a small but measurable risk of miscarriage, thereby supporting better maternal and fetal health outcomes. Key cities such as Hanoi and Ho Chi Minh City dominate the market due to their higher population density, advanced healthcare infrastructure, and access to specialized medical services. These urban centers are also home to a growing number of tertiary hospitals, private diagnostic laboratories, and obstetric clinics that offer NIPT and other advanced prenatal screening services, making these tests more accessible to expectant mothers. The concentration of healthcare resources, trained genetic counselors, and partnerships with international genomics companies in these cities further enhances their market dominance. The Vietnamese government has strengthened the policy framework for prenatal and newborn screening through instruments such as Decision 1807/QD-BYT issued by the Ministry of Health in 2020 under the National Program on Expanded Newborn Screening and Prenatal Screening, which encourages integration of advanced screening methods, including noninvasive prenatal testing, into obstetric care pathways. These guidelines promote standardized prenatal screening protocols in antenatal clinics and hospitals, accompanied by counseling to ensure that expectant mothers receive clear information on the benefits, limitations, and availability of tests such as NIPT. The initiative is aligned with broader maternal and child health strategies, aiming to increase early detection of chromosomal and genetic disorders, reduce the burden of congenital anomalies, and improve maternal and fetal health outcomes across the country.

Vietnam Noninvasive Prenatal Testing Market Segmentation

By Test Type: The market is segmented into various test types, including Maternal Cell-free DNA (cfDNA) Testing, Combined First-Trimester Screening (Ultrasound + Serum Markers), Second-Trimester Serum Screening, Expanded NIPT Panels (Microdeletions and Other Aneuploidies), and Others. Maternal Cell-free DNA (cfDNA) Testing is the leading subsegment due to its high sensitivity and specificity for common aneuploidies and its ability to be performed from an early gestational age. The increasing preference for cfDNA testing is driven by its noninvasive nature, reduced need for follow-up invasive procedures, faster turnaround times, and the growing awareness among healthcare providers and patients regarding its clinical utility and favorable risk–benefit profile. By Clinical Application: The clinical applications of noninvasive prenatal testing include Trisomy 21 (Down Syndrome) Screening, Trisomy 18 (Edwards Syndrome) Screening, Trisomy 13 (Patau Syndrome) Screening, Sex Chromosome Aneuploidies, and Microdeletion and Other Genetic Disorders. Trisomy 21 Screening is the most prominent application, supported by the comparatively higher prevalence of Down Syndrome among live births and the strong clinical and economic rationale for early detection. The growing awareness of genetic disorders, increasing maternal age in urban populations, and the importance of early intervention and informed reproductive decision-making further contribute to the dominance of this application.

Vietnam Noninvasive Prenatal Testing Market Market Opportunities

The Vietnam Noninvasive Prenatal Testing Market is characterized by a dynamic mix of regional and international players. Leading participants such as Natera, Inc., Illumina, Inc., Roche Diagnostics, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, PerkinElmer, Inc., Eurofins Scientific, BGI Genomics Co., Ltd., Myriad Genetics, Inc., F. Hoffmann-La Roche Ltd – NIPT Portfolio, MedGenome, Sema4, Gene by Gene, and local Vietnamese diagnostic labs offering NIPT contribute to innovation, geographic expansion, and service delivery in this space. Natera, Inc. 2003 Austin, Texas, USA

Illumina, Inc. 1998 San Diego, California, USA

Roche Diagnostics

1896 Basel, Switzerland

Laboratory Corporation of America Holdings (LabCorp)

1971 Burlington, North Carolina, USA

Quest Diagnostics Incorporated

1967 Secaucus, New Jersey, USA

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Vietnam NIPT Revenue (USD Million)

3-year Revenue CAGR (%) in Vietnam

Vietnam Market Share (%)

Number of NIPT Tests Performed Annually (Volume)

Average Selling Price per Test (USD)

Vietnam Noninvasive Prenatal Testing Market Industry Analysis

Growth Drivers

Increasing Awareness of Prenatal Health: The Vietnamese government has prioritized maternal health, leading to a 20% increase in prenatal health awareness campaigns since 2020. This has resulted in a significant rise in the number of expectant mothers seeking noninvasive prenatal testing (NIPT). In future, approximately 1.5 million prenatal tests are expected to be conducted, reflecting a growing recognition of the importance of early disease detection and maternal well-being, supported by the World Health Organization's initiatives. Rising Demand for Early Disease Detection: With congenital disorders affecting around 1 in 33 births in Vietnam, the demand for early disease detection through NIPT has surged. In future, it is estimated that 50% of pregnant women will opt for NIPT, driven by the desire for timely interventions. This trend is bolstered by increasing healthcare expenditure, projected to reach $25 billion, enhancing access to advanced testing technologies and services across urban and rural areas. Technological Advancements in Testing Methods: The introduction of next-generation sequencing (NGS) technology has revolutionized NIPT in Vietnam, improving accuracy rates to over 98%. In future, the number of laboratories offering NIPT is expected to increase by 30%, reflecting the rapid adoption of these advanced methodologies. This technological shift is supported by a 10% annual growth in the biotechnology sector, fostering innovation and accessibility in prenatal testing services nationwide.

Market Challenges

High Cost of Testing Procedures: The average cost of NIPT in Vietnam is approximately $600, which poses a significant barrier for many families, especially in lower-income brackets. With over 15% of the population living below the poverty line, affordability remains a critical challenge. This high cost limits access to essential prenatal testing, despite the increasing awareness and demand for such services, hindering overall market growth. Limited Access in Rural Areas: Approximately 65% of Vietnam's population resides in rural areas, where access to advanced healthcare services, including NIPT, is severely restricted. Only 20% of rural healthcare facilities offer prenatal testing, creating a significant disparity in healthcare access. This limitation is exacerbated by inadequate transportation infrastructure, which further complicates access to urban healthcare centers, impacting the overall uptake of NIPT services.

Vietnam Noninvasive Prenatal Testing Market Future Outlook

The future of the Vietnam noninvasive prenatal testing market appears promising, driven by ongoing advancements in technology and increasing healthcare investments. As the government continues to implement policies aimed at improving maternal health, the integration of telemedicine and AI in prenatal care is expected to enhance service delivery. Additionally, the growing emphasis on personalized medicine will likely lead to more tailored testing solutions, further expanding the market's reach and accessibility across diverse demographics.

Market Opportunities

Expansion of Healthcare Infrastructure: The Vietnamese government plans to invest $10 billion in healthcare infrastructure by 2025, which will significantly enhance access to NIPT services. This investment is expected to improve facilities in underserved areas, allowing more women to benefit from advanced prenatal testing and ultimately reducing health disparities across the country. Development of Cost-Effective Testing Solutions: There is a growing opportunity for companies to innovate and develop cost-effective NIPT solutions, targeting the lower-income demographic. By leveraging local resources and technology, firms can create affordable testing options, potentially increasing market penetration and improving maternal health outcomes for a larger segment of the population.

Please Note: The report will take approximately 4–6 weeks to prepare and deliver.

Update cycle typically involves:

Dataset refresh & triangulation from credible public sources + paid databases where applicable.
Competitive mapping (platform coverage, business model, revenue/traffic proxies where available, key vertical splits)
Validation pass to ensure numbers are directionally consistent (and avoid “stale” assumptions)
Finalizing the PDF + Excel with clear assumptions and definitions. Show more